The GABA uptake inhibitor β-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis
详细信息 查看全文
- 作者：Ishiwari ; Keita ; Mingote ; Susana ; Correa ; Merce ; Trevitt ; Jennifer T. ; Carlson ; Brian B. ; Salamone ; John D.
- 关键词：Basal ganglia ; Striatonigral ; Acetylcholine ; Parkinson's disease ; Muscarinic ; Dialysis
- 刊名：Journal of Neuroscience Methods
- 出版年：2004
- 出版时间：December 30, 2004
- 年：2004
- 卷：140
- 期：1-2
- 页码：39-46
- 全文大小：236 K
文摘
Substantia nigra pars reticulata (SNr) is a major output nucleus of the basal ganglia that receives GABAergic projections from neostriatum and globus pallidus. Previous research has shown that local pharmacological manipulations of GABA in SNr can influence tremulous jaw movements in rats. Tremulous jaw movements are defined as rapid vertical deflections of the lower jaw that resemble chewing but are not directed at a particular stimulus, and evidence indicates that these movements share many characteristics with parkinsonian tremor in humans. In order to investigate the role of GABA in motor functions related to tremor, the present study tested the GABA uptake blocker β-alanine for its ability to reduce pilocarpine-induced tremulous jaw movements. In a parallel experiment, the effect of an active dose of β-alanine on dialysate levels of GABA in SNr was assessed using microdialysis methods. GABA levels in dialysis samples were measured using high performance liquid chromatography with electrochemical detection. β-Alanine (250–500mg/kg) significantly reduced tremulous jaw movements induced by pilocarpine (4.0mg/kg). Moreover, systemic administration of β-alanine at a dose that reduced tremulous jaw movements (500mg/kg) resulted in a substantial increase in extracellular levels of GABA in SNr compared to the pre-injection baseline. Thus, the present results are consistent with the hypothesis that GABAergic tone in SNr plays a role in the regulation of tremulous jaw movements. This research may lead to a better understanding of how parkinsonian symptoms are modulated by SNr GABA mechanisms.